The date of Lynx's shareholder meeting is March 1, not March 21.
Under the new agreement with USC, Lynx will be paid for performing genome-wide transcriptome sequencing services on oyster samples, using its massive parallel signature sequencing technology.
Separately, Lynx said it will hold its 2004 annual meeting of stockholders on March 1, where shareholders will vote on the proposed merger with Solexa.
Lynx also said it will have a hearing before a Nasdaq listing qualifications panel on Feb. 9 to review Nasdaq's decision to delist the company from the Nasdaq SmallCap Market after Lynx failed to hold an annual stockholder meeting by Dec. 31, 2004.
"We believe that following the upcoming stockholders' meeting, Lynx will again be in full compliance with Nasdaq listing requirements," acting CEO Mary Schramke said in a statement today.